Stock 600080 GINWA ENTERPRISE (GROUP) INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Ginwa Enterprise (Group) Inc.

Equities

600080

CNE000000QQ8

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-29 pm EDT 		5-day change 1st Jan Change
6.78 CNY -0.29% Intraday chart for Ginwa Enterprise (Group) Inc. -0.29% -8.99%
Apr. 26 Ginwa Enterprise Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 26 Ginwa Enterprise Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Ginwa Enterprise Group Inc is a China-based company principally engaged in the research and development, production and sales of pharmaceuticals. The Company operates its businesses through three segments. The Pharmaceutical Industry segment is mainly engaged in the production of pharmaceuticals. The Company's products are divided into four series, including orthopedics, immunology, children's and general medicines, mainly covering chemicals, Chinese patent medicines, active pharmaceutical ingredient and health care products. The Hotel Industry segment is mainly engaged in the operation of hotels. The Pharmaceutical Commercial segment is mainly engaged in the sales of pharmaceuticals. The Company mainly operates its businesses in the domestic market.

Number of employees: 553

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceutical Industry
99.0 %
565 97.5 % 560 99.0 % -0.90%
Hospitality
0.8 %
14 2.4 % 5 0.8 % -65.83%
Pharmaceutical Business
0.1 %
0 0.0 % 1 0.1 % +123.58%
Inter-segment Eliminations
0.0 %
0 0.0 % 0 0.0 % +10.65%
Other
0.0 %
0 0.0 % 0 0.0 % -

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
579 100.0 % 565 100.0 % -2.41%

Managers

Managers TitleAgeSince
Zhuo Jun Han CEO
 Chief Executive Officer 57 -
Ming Sun DFI
 Director of Finance/CFO 52 99-12-31
Chuan Qin BRD
 Director/Board Member 61 94-12-31

Members of the board

Members of the board TitleAgeSince
Chuan Qin BRD
 Director/Board Member 61 94-12-31
Zhuo Jun Han CEO
 Chief Executive Officer 57 -
Ge Zhao BRD
 Director/Board Member 51 22-03-03
Zhao Yang Zhang BRD
 Director/Board Member 53 20-06-28
Xing Ya Jiang
57 -
Xiao Dong Cui BRD
 Director/Board Member 48 20-06-28
Ya Jiang Xing CHM
 Chairman 57 20-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 389,619,967 227,261,925 ( 58.33 %) 16,349,682 ( 4.196 %) 58.33 %

Shareholders

NameEquities%Valuation
Gfund Management Co., Ltd.
0.3837 %
1,171,300 0.3837 % 1 M ¥
China Asset Management Co., Ltd.
0.3602 %
1,099,800 0.3602 % 1 M ¥
Western Leadbank Fund Management Co., Ltd
0.2519 %
769,000 0.2519 % 756 096 ¥
Great Wall Fund Management Co., Ltd.
0.2043 %
623,800 0.2043 % 613 333 ¥
Hongde Fund Management Co., Ltd.
0.0661 %
201,800 0.0661 % 198 414 ¥
Lion Fund Management Co., Ltd.
0.0166 %
50,600 0.0166 % 49 751 ¥
Everbright PGIM Fund Management Co. Ltd.
0.0112 %
34,300 0.0112 % 33 724 ¥
Haitong Securities Asset Management Co., Ltd.
0.004618 %
14,100 0.004618 % 13 863 ¥
Fullgoal Fund Management Co., Ltd.
0.003832 %
11,700 0.003832 % 11 504 ¥
Guotai Asset Management Co., Ltd.
0.000491 %
1,500 0.000491 % 1 475 ¥

Company contact information

Ginwa Enterprise (Group) Inc.

40/F, South Building Gaoxin 3rd Road, Hi-tech Zone

710075, Xi'an

+

http://www.ginwa.com.cn
address Ginwa Enterprise (Group) Inc.(600080)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
GINWA ENTERPRISE (GROUP) INC. Stock Ginwa Enterprise (Group) Inc.
-8.99% 334M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+39.82% 734B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.55% 591B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.31% 350B
MERCK & CO., INC. Stock Merck & Co., Inc.
+14.23% 315B
ABBVIE INC. Stock AbbVie Inc.
+0.86% 276B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.04% 238B
ROCHE HOLDING AG Stock Roche Holding AG
-6.42% 204B
NOVARTIS AG Stock Novartis AG
+8.48% 206B
AMGEN INC. Stock Amgen Inc.
+4.51% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600080 Stock
  4. Company Ginwa Enterprise (Group) Inc.